Weight Reduction Medications and Programs

Admissions & application process

Payment for Weight loss Surgery
Alternative approaches based on Hanai mixture theory or vector analysis are in the early stages of investigation in neonates. The common side effects are nausea, constipation, headache, dry mouth, vomiting and dizziness. Reference lists of studies and reviews were manually searched. Advances in medical technology A 3-D view. They stated that future trials involving the use of this supplement should be more rigorous and better reported. Improvements in bad cholesterol, triglycerides and good cholesterol were also seen.

Background

Medical Weight Management

Shingles More common with age. Advances in medical technology A 3-D view. Sciatica Lower back and radiating leg pain. Pleural effusion Water on the lung. Stress incontinence Taking the next step. Rotator cuff injury Steps for shoulder pain.

Restless legs syndrome Unwanted urge to move. COPD When it's hard to breathe. How to outsmart salt at the grocery store. Subscribe Now Subscribe today and get access to special reports instantly! Current Issue October Cover Story Carpal tunnel syndrome Protecting hand nerves Carpal tunnel syndrome can cause numbness, burning or tingling in the hand, and in the thumb, index, middle and half of the ring finger. Featured Articles Vaginal atrophy Dining out well Flu season.

News and Our View Fitness and weight control both matter for heart health Nasal spray to provide rapid depression relief under study. Quiz Food poisoning An estimated 1 in 6 Americans gets food or beverage poisoning each year. Food poisoning An estimated 1 in 6 Americans gets food or beverage poisoning each year.

I have a treadmill stress test scheduled to look for heart disease. Contact your provider prior to beginning the program to find out what they cover. Opti is a three phase program. During the first weeks — the active weight-loss phase — you will consume full meal replacements with Optifast products.

During the transition program, you move to eating regular food you make yourself. Optifast is best for patients with a BMI of over It is recommended only as part of a comprehensive treatment program. But, we have notices that Dietspotlight Burn offers a trial; make sure to check it out! Optifast is a total program aimed at weight management.

It combines educational material related to lifestyle and the regular monitoring of medical issues with a diet focused on meal replacement. More details about the Optifast program can be obtained via a one hour consultation with a professional at a clinic in your area. To date, Optifast has not been tested for the presence of gluten.

However, it is noted that quite a few of the products are comprised only of gluten free ingredients. As such, they are appropriate for individuals who have an intolerance to gluten or have been diagnosed with Coeliac Disease. Some of the more notable ingredients in the Vanilla version Optifast are: There are calories in a vanilla shake made by Optifast. Other nutritional components in 5 grams of total fat and 0 grams of sugar. An HMR Diet is extremely regimented in order to facilitate the weight lost process.

A Weight loss plan that makes of HMR associated foods will use these meals and snacks in deference to other choices available on the market in order to eliminate the guesswork out of choosing what to eat.

HMR foods include snack bars, multigrain hot cereal, pudding, various entrees, and shakes. There is actually quite a variety of allowed vegetables and food that you can eat when in on the Optifast program. Some of the more notable vegetables that are allowed include green beans, alfalfa sprouts, eggplant, bean sprouts, cucumbers, bok choy, celery, cauliflower, carrots, capsicum, brussel sprouts, and cabbage.

Summer Banks, Director of Content at Dietspotlight, has researched over weight-loss programs, pills, shakes and diet plans. Previously, she managed 15 supplement brands, worked with professionals in the weight loss industry and completed coursework in nutrition at Stanford University.

Do Not Send Email Notifications. Problem is, I gained back 20 of the 40 lbs I lost within 2 months, and really have been eating fairly sensibly. My clothes are so loose. Jackie, the first 2 weeks were the hardest! Stick with it honey. I have lost lbs in a year. I did the Optifast program along with excercise. Like any other diet you have to stick with it. Best program I have ever done. I have been on the optifast meal replacements for about 2 weeks now and it is the hardest thing i have done up to date.

I also need to lose lbs and so far i have lost 20lbs in 2 weeks. My question to you is, about how many pounds did you average to lose per week and what type of exercise did you do and are doing? It is an amazing product. I love the Vanilla Powder Shakes. I blend it together with water, ice, powder and a sprinkle of Starbucks instant coffee. I have been on Optifast for six months. I have lost 60 pounds. I drink two shakes a day and a Lean Cuisine for dinner.

In the beginning, I did three shakes and two cups of veggies. After three-four weeks, I switched to the shakes a day. I could do this the rest of my life. Have been on Optifast for 3 weeks have only lost 5 pounds. Last week I gained 1 pound. What the hell is going on? I have followed the program with 4 products and 1 meal a day. I am on quite a bit of meds for A fib and Hypertension.

Could it be that I have very painful arthritis and cannot do much activity? I am ready to quit. It is sooo expensive not to have lost any more than 5 pounds. It should be 6 products a day and lots of water. I do have fibromyalgia problems at one time I gained 40 pounds in 4 months and years later they tried me another medication I gained 30 pounds in 3 months I had to stop at medication being so heavy was worse on my health than the fibromyalgia pain alone.

I have been on the program 70 days, lost 35 pounds and have not felt this great in a long time. The program is not cheap by any means but I have multiple medical issues, needed to lose a lot of weight, They follow my progress at least weekly and are availabe to help me if I have a problem.

There is also a support group when you complete the program. This is not a program for those who want the easy way out, you also have to work exercise to achieve.

Make sure you are including some benefiber-type product for bulk in your diet. Could be constipation related. Benefiber is more expensive but you can buy a house brand at CVS that is more reasonable. Optifast is a medically supervised program. Call her doctor immediately.

She could have a gallstone problem. I just started optifast yesterday. Today, after slight exertion I found myself sweating profusely and not feeling good. Prior to eating I did a fingerstick and it was , the highest its ever been fasting. Can anyone explain why this happened? When I started Optifast my doctor warned me that my blood sugar could bounce all over the place initially since I stopped all diabetic pills when I started Optifast.

I have been lucky and my blood sugars have been between 94 and Give it a little time and you should level out. The way I look at it depends on what you spend on food for your household and how much you eat but and maybe a few dollars extra than what you spend normally but which is way worth it! How much sugar is in each shake? That would easily raise blood sugar. Especially without the added fat to slow digestion.

They contain milk products and all contain about 1gm of lactose, except for the vanilla powder, which contains grams of lactose. I just my first 2 weeks on the opti-fast So far its been 3 days, anyone finding 4 shakes a day hard? I know I am, there are so filling. Plus I have to drink tons of water. I hope the weight loss starts soon. Percentage of fat mass change was calculated in when possible.

Findings suggested, no changes were observed in fat free mass after 16 weeks of nutritional intervention and the lowest decrease on fat mass percentage was obtained. However, the highest fat mass percentage with parallel increase in fat free mass, both assessed by DXA was observed in a multi-component intervention applied for 20 weeks.

The authors concluded that more studies are needed to determine the best field body composition method to monitor changes during overweight treatment in children and adolescents.

Two reviewers independently screened titles and abstracts for inclusion, extracted data and rated methodological quality of the included studies. These investigators performed a best evidence synthesis to synthesize the results, thereby excluding studies of poor quality. They included 50 published studies. Mean differences between BIA and reference methods gold standard [criterion validity] and convergent measures of body composition [convergent validity] were considerable and ranged from negative to positive values, resulting in conflicting evidence for criterion validity.

These investigators found strong evidence for a good reliability, i. However, test-retest mean differences ranged from 7. However, they stated that validity and measurement error were not satisfactory.

Goldberg et al stated that the sensory and gastro-intestinal changes that occur with aging affect older adults' food and liquid intake. Any decreased liquid intake increases the risk for dehydration. This increased dehydration risk is compounded in older adults with dysphagia. The availability of a non-invasive and easily administered way to document hydration levels in older adults is critical, particularly for adults in residential care. This pilot study investigated the contribution of BIA to measure hydration in 19 older women in residential care: The authors concluded that if results are confirmed through continued investigation, such findings may suggest that long-term care facilities are unique environments in which all older residents can be considered at-risk for dehydration and support the use of BIA as a non-invasive tool to assess and monitor their hydration status.

Buffa et al defined the effectiveness of bioelectrical impedance vector analysis BIVA for assessing 2-compartment body composition. Selection criteria included studies comparing the results of BIVA with those of other techniques, and studies analyzing bioelectrical vectors of obese, athletic, cachectic and lean individuals.

A total of 30 articles met the inclusion criteria. The ability of classic BIVA for assessing 2-compartment body composition has been mainly evaluated by means of indirect techniques, such as anthropometry and BIA. Classic BIVA showed a high agreement with body mass index, which can be interpreted in relation to the greater body mass of obese and athletic individuals, whereas the comparison with BIA showed less consistent results, especially in diseased individuals.

The authors concluded that specific BIVA is a promising alternative to classic BIVA for assessing 2-compartment body composition, with potential application in nutritional, sport and geriatric medicine. Haverkort et al noted that BIA is a commonly used method for the evaluation of body composition. However, BIA estimations are subject to uncertainties.

These researchers explored the variability of empirical prediction equations used in BIA estimations and evaluated the validity of BIA estimations in adult surgical and oncological patients. Studies developing new empirical prediction equations and studies evaluating the validity of BIA estimations compared with a reference method were included. Only studies using BIA devices measuring the entire body were included. Studies that included patients with altered body composition or a disturbed fluid balance and studies written in languages other than English were excluded.

To illustrate variability between equations, fixed normal reference values of resistance values were entered into the existing empirical prediction equations of the included studies and the results were plotted in figures. Estimates of the FM demonstrated large variability range relative difference The authors concluded that application of equations validated in healthy subjects to predict body composition performs less well in oncologic and surgical patients.

They suggested that BIA estimations, irrespective of the device, can only be useful when performed longitudinally and under the same standard conditions. Gibson et al stated that VLEDs and ketogenic low-carbohydrate diets KLCDs are 2 dietary strategies that have been associated with a suppression of appetite. However, the results of clinical trials investigating the effect of ketogenic diets on appetite are inconsistent.

To evaluate quantitatively the effect of ketogenic diets on subjective appetite ratings, these researchers conducted a systematic literature search and meta-analysis of studies that assessed appetite with visual analog scales VAS before in energy balance and during while in ketosis adherence to VLED or KLCD. Although these absolute changes in appetite were small, they occurred within the context of energy restriction, which is known to increase appetite in obese people.

Thus, the clinical benefit of a ketogenic diet is in preventing an increase in appetite, despite weight loss, although individuals may indeed feel slightly less hungry or more full or satisfied. Ketosis appears to provide a plausible explanation for this suppression of appetite. The authors concluded that future studies should investigate the minimum level of ketosis required to achieve appetite suppression during ketogenic weight loss diets, as this could enable inclusion of a greater variety of healthy carbohydrate-containing foods into the diet.

Bueno and colleagues examined the effect of replacing dietary long-chain triacylglycerols LCTs with medium-chain triacylglycerols MCTs on body composition in adults. These researchers conducted a meta-analysis of RCTs, to examine if individuals assigned to replace at least 5 g of dietary LCTs with MCTs for a minimum of 4 weeks show positive modifications on body composition. Two authors independently extracted data and assessed risk of bias. Weighted mean differences WMDs were calculated for net changes in the outcomes.

These investigators assessed heterogeneity by the Cochran Q test and I 2 statistic and publication bias with the Egger's test. Pre-specified sensitivity analyses were performed. A total of 11 trials were included, from which 5 presented low risk of bias. The overall quality of the evidence was low-to-moderate.

Trials with a cross-over design were responsible for the heterogeneity. The authors concluded that despite statistically significant results, the recommendation to replace dietary LCTs with MCTs must be cautiously taken, because the available evidence is not of the highest quality.

Changes in blood lipid levels were secondary outcomes. Identified trials were assessed for bias. Mean differences were pooled and analyzed using inverse variance models with fixed effects. Heterogeneity between studies was calculated using I 2 statistic. No differences were seen in blood lipid levels.

Many trials lacked sufficient information for a complete quality assessment, and commercial bias was detected. Although heterogeneity was absent, study designs varied with regard to duration, dose, and control of energy intake.

The authors concluded that replacement of LCTs with MCTs in the diet could potentially induce modest reductions in body weight and composition without adversely affecting lipid profiles. However, they stated that further research is needed by independent research groups using large, well-designed studies to confirm the effectiveness of MCT and to determine the dosage needed for the management of a healthy body weight and composition. They performed a search of English-language articles in the PubMed and Embase databases through April 30, Differences in weight loss between FTO genotypes across studies were pooled with the use of fixed-effect models.

A meta-analysis of 10 studies comprising 6, participants that reported the results of additive genetic models showed that individuals with the FTO TA genotype and AA genotype those with the obesity-predisposing A allele had 0. A meta-analysis of 14 studies comprising 7, participants that reported the results of dominant genetic models indicated a 0. In addition, differences in weight loss between the AA genotype and TT genotype were significant in studies with a diet intervention only, adjustment for baseline BMI or body weight, and several other subgroups.

However, the relatively small number of studies limited these stratified analyses, and there was no statistically significant difference between subgroups. Hypoxic conditioning has been previously used by healthy and athletic populations to enhance their physical capacity and improve performance in the lead up to competition.

Recently, HC has also been applied acutely single exposure and chronically repeated exposure over several weeks to over-weight and obese populations with the intention of managing and potentially increasing cardio-metabolic health and weight loss. At present, it is unclear what the cardio-metabolic health and weight loss responses of obese populations are in response to passive and active HC.

Exploration of potential benefits of exposure to both passive and active HC may provide pivotal findings for improving health and well-being in these individuals. These researchers carried out a systematic literature search for articles published between and Studies investigating the effects of normobaric HC as a novel therapeutic approach to elicit improvements in the cardio-metabolic health and weight loss of obese populations were included. Inconclusive findings, however, exist in determining the impact of acute and chronic HC on markers such as triglycerides, cholesterol levels, and fitness capacity.

The authors concluded that normobaric HC demonstrated observable positive findings in relation to insulin and energy expenditure passive , and body weight and BP active , which may improve the cardio-metabolic health and body weight management of obese populations. However, they stated that further evidence on responses of circulating biomarkers to both passive and active HC in humans is needed. The following indicates maximum ideal weight in shoes with one-inch heels based on body frame and height:.

Clinical Policy Bulletin Notes. Links to various non-Aetna sites are provided for your convenience only. Weight Reduction Medications and Programs. Aetna considers the following medically necessary treatment of obesity when criteria are met: Weight reduction medications, and.

Dexamethasone suppression test and hour urinary free cortisol measures if symptoms suggest Cushing's syndrome. Rice diet or other special diet supplements e. American Obesity Association, C. Guidance for treatment of adult obesity.

Accessed March 16, Long-term pharmacotherapy in the management of obesity. Gain and loss in weight. Department of Agriculture and U. Department of Health and Human Services. Nutrition and your health: Dietary guidelines for Americans. Home and Garden Bulletin. Government Printing Office; The effect of pharmacologic agents. Am J Clin Nutr. United States Pharmacopeial Convention, Inc. Drug Information for the Health Care Professional. United States Pharmacopeial Convention; Introductory Nutrition and Diet Therapy.

Drugs used in obesity. Therapy for obesity--today and tomorrow. Baillieres Clin Endocrinol Metab. Use and abuse of appetite-suppressant drugs in the treatment of obesity. American Society of Health-System Pharmacists; Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The acute 1-week effects of the Zone diet on body composition, blood lipid levels, and performance in recreational endurance athletes.

J Strength Cond Res. Haller C, Schwartz JB. Pharmacologic agents for weight reduction. J Gend Specif Med. Weight loss with self-help compared with a structured commercial program: Pharmacological approaches to weight loss in adults. Technology Assessment Report No.

Admissions